SOURCE: Hansen Medical, Inc.

June 05, 2008 19:25 ET

Hansen Medical to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

MOUNTAIN VIEW, CA--(Marketwire - June 5, 2008) - Hansen Medical, Inc. (NASDAQ: HNSN) announced today that its Co-Founder and Chief Executive Officer, Fred Moll, M.D., will present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference. The conference is being held June 11-12, 2008 at The New York Palace Hotel. Hansen Medical is scheduled to present on Thursday, June 12, 2008 at 9:00 a.m. ET.

Hansen Medical will provide a live webcast of the audio presentation. Interested parties may access the live webcast by visiting the investor relations section of Hansen Medical's web site at A replay of the webcast will be available at the site after the live presentation.

About Hansen Medical, Inc.

Hansen Medical Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food & Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of atrial fibrillation (AF).

The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established. Additional information can be found at

Contact Information